This test is most useful if any of these apply to you.
Your liver constantly transforms compounds you absorb from food, and the resulting molecules end up in your urine. DHPPA (3,5-dihydroxyphenylpropionic acid) is one of those metabolites. It shows up when your body processes alkylresorcinols, plant compounds concentrated in the outer bran layer of whole-grain wheat and rye.
Measuring DHPPA gives you an objective check on how much whole grain has actually reached and been absorbed by your body in recent days. It can verify whether self-reported diet matches actual intake, since food questionnaires often miss the mark. This is a research-grade nutritional biomarker without standardized clinical cutpoints, best interpreted alongside other tests rather than on its own.
DHPPA is produced when your liver metabolizes alkylresorcinols, plant compounds concentrated in whole-grain wheat and rye. Alkylresorcinols are absorbed in the small intestine, enter the bloodstream, and are then broken down by the liver (through enzymes including CYP4F2) into DHPPA and a related metabolite called DHBA. These are excreted in urine. Levels in urine track dietary intake over hours to days and respond when people switch between whole-grain and refined-grain diets.
A different compound that often gets discussed alongside DHPPA on the same lab panels is 3-(3-hydroxyphenyl)-3-hydroxypropionic acid, abbreviated HPHPA. Unlike DHPPA, HPHPA is a true microbial metabolite: it is produced by anaerobic bacteria of the Clostridium genus from the amino acid phenylalanine (via an intermediate called m-tyrosine). HPHPA and DHPPA are chemically distinct and reported as separate analytes, and they reflect very different biology: DHPPA tracks dietary whole-grain intake, while HPHPA tracks Clostridia activity in the gut.
In a one-year study of 482 Chinese community-dwelling adults, higher urinary DHPPA tracked with better cardiometabolic profiles. People excreting more DHPPA had lower total cholesterol, lower LDL cholesterol, and lower levels of two inflammation markers, interleukin-6 and C-reactive protein. The pattern points to DHPPA as a real-world readout of how much whole grain is actually making it into your system, which self-reported diet questionnaires often get wrong.
In a separate study of 306 adults, higher urinary alkylresorcinol metabolites (including DHPPA) were linked to lower body weight, lower BMI, less body fat, less visceral fat (the deep belly fat wrapped around organs), and less liver fat. These are associations, not proof that DHPPA itself causes the benefit, but the signal is consistent: when more of this metabolite is being produced from whole-grain intake, the rest of your metabolism tends to look healthier.
When the related marker HPHPA is reported alongside DHPPA, it reflects Clostridia activity in the gut, and the clinical meaning shifts. In one observational report, children with autism showed higher urinary HPHPA than age and sex-matched controls. The same report described an acutely psychotic adult whose HPHPA level was very high compared to typical adult values, and whose symptoms improved alongside a sharp drop in HPHPA after treatment with oral vancomycin, an antibiotic that targets Clostridia. A separate adult with recurrent Clostridium difficile diarrhea also showed elevated levels.
These are limited human observations from a small body of work, not large outcome trials. The biological idea is that HPHPA and related Clostridia metabolites may interfere with dopamine and norepinephrine signaling, the brain chemicals that govern mood, attention, and movement. Whether mildly elevated HPHPA matters for an otherwise healthy adult is not yet established, which is why these markers sit in the research and exploratory category rather than the standard clinical workup.
A nested case-control study from the Japan Public Health Center cohort looked at prediagnostic plasma concentrations of several polyphenol metabolites in relation to colon cancer risk. Some metabolites in the broader phenolic acid family (such as 3,4-dihydroxyphenylpropionic acid, ferulic acid, and caffeic acid) showed inverse trends with colon cancer risk, while DHPPA itself (3,5-dihydroxyphenylpropionic acid) showed a positive trend in men. Importantly, none of these associations remained statistically significant after correction for multiple comparisons, and the study measured plasma rather than urine. The takeaway is not that DHPPA predicts colon cancer in either direction, but that polyphenol metabolites as a class are being actively studied for their relevance to gut and colon health.
Urinary DHPPA bounces around with what you ate yesterday. A bowl of whole-grain rye porridge in the morning can raise levels by evening. A week of refined breads and pasta can drop them. This sensitivity is what makes DHPPA useful for tracking dietary patterns, but it also means a single spot urine sample captures a moment, not a steady state.
Most labs normalize urinary DHPPA to creatinine, which is a waste product of muscle metabolism excreted in urine. This adjustment can mislead when comparing people on very different diets. Omnivores excrete more creatinine because they eat more meat and fish, which can artificially deflate any creatinine-adjusted biomarker compared to vegetarians or vegans, even when the true excretion is similar. Specific-gravity adjustment reduces but does not eliminate this issue.
Because DHPPA reflects what you ate in the recent past, a single number tells you about a window, not a trend. The value comes from watching the trajectory across multiple measurements taken under similar conditions. If you change your diet, repeating the test after a few weeks shows whether the change is actually reflected in objective biomarker output.
A reasonable cadence for someone using DHPPA as a research-grade tracking marker: get a baseline, retest in 3 to 6 months if you are actively changing your diet, then at least annually thereafter. If you are using the result to evaluate a specific dietary intervention, plan the retest for after the intervention has had time to work, usually 8 to 12 weeks.
DHPPA does not stand on its own. An unusual reading is most useful when paired with other markers from the same urine panel, such as HPHPA, 4-cresol, 3-indoleacetic acid, and other organic acids that together sketch a picture of dietary intake and microbial activity. A high DHPPA alongside high HPHPA points toward a different combination than high DHPPA with otherwise unremarkable microbial markers.
If your number sits well outside what your lab considers typical and you are not sure why, the practical next steps are to repeat the test under consistent conditions, look at companion markers, and consider a stool-based test like a GI-MAP or comprehensive stool analysis if microbial questions are on the table. A clinician trained in functional or integrative medicine, gastroenterology, or clinical nutrition can help integrate the result with your dietary history and symptoms. Do not act on a single isolated reading without context.
Evidence-backed interventions that affect your DHPPA level
DHPPA is best interpreted alongside these tests.
DHPPA is included in these pre-built panels.